Results
8577
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,577 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ACI | ₹687.85 | 0.6% | 28.5% | ₹84.9b | ₹890.14 | PE38.6x | E42.1% | 0.4% | Materials | ||
DOMS | ₹2,679.55 | -3.7% | n/a | ₹162.6b | ₹2,894.14 | PE87.6x | E23.5% | 0.09% | Commercial Services | ||
ANUP | ₹3,500.05 | 6.9% | 156.6% | ₹70.0b | ₹3,850.00 | PE58.5x | E21.5% | 0.2% | Capital Goods | ||
6181 | HK$190.30 | -15.3% | n/a | HK$32.0b | HK$204.40 | PE36.9x | E33.9% | n/a | Consumer Durables | ||
ICOP | €7.22 | 1.7% | n/a | €199.5m | €9.30 | PE39.5x | E49.2% | n/a | Capital Goods | ||
TGTX | US$30.91 | 19.5% | 182.3% | US$4.4b | US$37.22 | PS16.8x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$46.45 | 11.0% | 170.1% | US$7.7b | US$37.58 | PS35.5x | E95.0% | n/a | Semiconductors | ||
NVG | zł1.70 | -0.9% | -15.3% | zł59.4m | zł3.65 | PE219x | E41.3% | 3.5% | Diversified Financials | ||
ACE | SEK 2.55 | 19.2% | -9.9% | SEK 245.0m | SEK 8.25 | PB2.3x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
MVW | NOK 9.30 | -7.9% | 35.2% | NOK 304.3m | NOK 12.20 | PS17.7x | E70.8% | n/a | Materials | ||
RMDA | ج.م3.58 | -2.7% | 136.8% | ج.م5.4b | ج.م4.11 | PE23.7x | E30.2% | 1.9% | Pharmaceuticals & Biotech | ||
PHM | €79.85 | 6.4% | 117.2% | €1.4b | €84.60 | PE2251.6x | E56.4% | 0.8% | Pharmaceuticals & Biotech | ||
FWRY | ج.م8.44 | 6.7% | 75.1% | ج.م28.8b | ج.م11.39 | PE29.8x | E28.7% | n/a | Diversified Financials | ||
ALKT | US$37.60 | 0.6% | 67.6% | US$3.8b | US$44.30 | PS12x | E98.6% | n/a | Software | ||
EH | US$15.84 | -14.1% | 12.1% | US$1.1b | US$24.35 | PS29.1x | E81.4% | n/a | Capital Goods | ||
TVTX | US$18.75 | 5.6% | 207.9% | US$1.5b | US$26.38 | PS7.2x | E72.6% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$268.95 | 1.4% | 58.2% | US$36.1b | US$301.40 | PS16.6x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
GAU | CA$2.01 | -10.3% | 168.0% | CA$498.4m | CA$3.51 | PS2.2x | E89.2% | n/a | Materials | ||
CCOLA | ₺46.40 | 2.8% | 24.1% | ₺129.8b | ₺85.53 | PE10.1x | E42.0% | 1.5% | Food, Beverage & Tobacco | ||
AXSM | US$99.49 | 11.5% | 58.8% | US$4.4b | US$127.53 | PS16.4x | E68.7% | n/a | Pharmaceuticals & Biotech | ||
AFISH | NOK 70.00 | -7.3% | -12.5% | NOK 2.2b | NOK 81.00 | PE68x | E94.4% | n/a | Food, Beverage & Tobacco | ||
ARES | US$170.50 | 3.7% | 55.3% | US$53.7b | US$172.31 | PE79.6x | E33.4% | 2.2% | Diversified Financials | ||
CADLR | NOK 68.40 | -7.3% | 101.7% | NOK 24.0b | NOK 81.79 | PS16.6x | E67.9% | n/a | Capital Goods | ||
ZVRA | US$8.57 | -0.5% | 96.6% | US$471.5m | US$20.43 | PS19x | E69.7% | n/a | Pharmaceuticals & Biotech |